MktsMarkets

ANI Pharmaceuticals, Inc.
NASDAQ: ANIPKey statistics
ANIP News
Stories mentioning ANIP from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 237,462 | 247,060 | 227,813 | 211,371 | 197,122 | 190,574 | 148,332 | 138,040 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 10,600 | 12,261 | 12,304 | 16,535 | 10,564 | 16,646 | 10,128 | 7,296 |
| Sales General & Admin | 73,655 | 82,790 | 76,656 | 81,771 | 76,528 | 69,719 | 79,075 | 52,821 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 38,888 | 34,767 | 36,240 | 13,892 | 26,194 | (4,378) | (20,519) | 5,169 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (651.00) | 850.00 | (853.00) | 1,739 | 198.00 | (1,378) | (2,535) | (88.00) |
| Pretax Income | 40,221 | 31,479 | 33,800 | 10,525 | 19,987 | (13,762) | (31,498) | (2,287) |
| Tax Provision | 10,729 | 3,989 | 7,183 | 1,976 | 4,306 | (3,486) | (7,332) | 0.00 |
| Net Income (Loss) | 29,492 | 27,490 | 26,617 | 8,549 | 15,681 | (10,276) | (24,166) | (2,287) |
| Earnings Per Share (Basic) | 1.31 | 1.37 | 1.19 | 0.37 | 0.70 | (0.53) | (1.27) | (0.14) |
| Earnings Per Share (Diluted) | 1.28 | 1.29 | 1.13 | 0.36 | 0.69 | (0.53) | (1.27) | (0.14) |
| Weighted Average Shares Outstanding (Basic) | 20,914 | 20,053 | 20,074 | 19,834 | 19,607 | 19,318 | 19,404 | 19,321 |
| Weighted Average Shares Outstanding (Diluted) | 21,544 | 21,228 | 21,093 | 20,308 | 20,046 | 19,318 | 19,404 | 19,321 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ANIP
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is a stock listed on the Nasdaq Stock Market under the ticker symbol ANIP. It last traded at $72.61 (Oct 23, 2026, 4:00 PM ET), down 1.6% on the day. That gives ANI Pharmaceuticals a market capitalisation of $1.7B and a price-to-earnings ratio of 15.4.
Over the past 52 weeks ANIP has traded between $69.58 and $97.00.
Revenue for the quarter ended Mar 31, 2026 was $237.5M; net income $29.5M. Revenue was up 20.5% from $197.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $237.5M | $29.5M | 12.4% |
| Dec 31, 2025 | $247.1M | $27.5M | 11.1% |
| Sep 30, 2025 | $227.8M | $26.6M | 11.7% |
| Jun 30, 2025 | $211.4M | $8.5M | 4.0% |
From ANI Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…